¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"N methyl D aspartate receptor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® receptor ÇÑ±Û ¼ö¿ëü
¼³¸í   
  ¼¼Æ÷Áú³» ¶Ç´Â ¼¼Æ÷Ç¥¸é¿¡ Á¸ÀçÇϴ ºÐÀÚ±¸Á¶·Î¼­ Æ¯À̹°Áú°ú ¼±ÅÃÀûÀ¸·Î °áÇÕÇϸ砰áÇÕ¿¡ ÀÇÇØ Æ¯ÀÌÇÑ »ý¸®Àû ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÆéƼµåÈ£¸£¸ó, ½Å°æÀü´Þ¹°Áú, Ç׿ø, º¸Ã¼, ¸é¿ª±Û·ÎºÒ¸°¿¡ ´ëÇÑ ¼¼Æ÷Ç¥¸é ¼ö¿ëü¿Í ½ºÅ×·ÎÀ̵忡 ´ëÇÑ ¼¼Æ÷Áú³» ¼ö¿ëü°¡ ÀÖ´Ù.
¿µ¹® aspartate aminotransferase(AST) ÇÑ±Û ¾Æ½ºÆÄ¶óÁø»ê ¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
¼³¸í   
  SGOT(Serum Glutamic Oxalacetic Transaminase)¶ó°íµµ Çϴ À̰ÍÀº Á¤»óÀûÀ¸·Î °£¼¼Æ÷¿Í ±ÙÀ°¼¼Æ÷ µî¿¡ ¸î°¡Áö µ¿Á¾È¿¼Ò(±â´ÉÀº °°Áö¸¸ ±¸Á¶°¡ ¾à°£¾¿ ´Ù¸¥ È¿¼ÒÇüÅÂ)ÀÇ ÇüÅ·ΠÁ¤»óÀûÀ¸·Î Á¸ÀçÇÑ´Ù. ±ÙÀ°¼¼Æ÷³ª °£¼¼Æ÷ÀÇ ÆÄ±«°¡ ¿À´Â °£º´À̳ª ±ÙÀ°º´¿¡¼­ Ç÷¾×¿¡ Àִ ÀÌ È¿¼ÒÀÇ ¾çÀÌ ÇöÀúÇϰԠÁõ°¡ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspartate aminotransferase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
  • aspartate transaminase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÚ¿Ã
  • methyl group
    ¸ÞÆ¿±â
  • antigen binding receptor
    Ç׿ø°áÇÕ¼ö¿ëü
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • adrenergic receptor
    ¾Æµå·¹³¯¸°¼ö¿ëü
  • androgen receptor
    ¾Èµå·Î°Õ¼ö¿ëü
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈ­È¿¼Ò
  • cold receptor
    ³Ã°¢¼ö¿ë±â
  • complement receptor
    º¸Ã¼¼ö¿ëü
  • corpuscular receptor
    ¼Òü¼ö¿ëü
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • cholinergic receptor
    Äݸ°¼ö¿ëü
  • distance receptor
    ¿ø°Ý¼ö¿ë±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspartate aminotransferase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
  • methyl prednisolone
    ¸ÞÆ¿ÇÁ·¹µå´Ï¼Ö·Ð
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor
    ¼ö¿ëü, ¼ö¿ë±â
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • opiate receptor
    ¾ÆÆí¼ö¿ëü
  • sensory receptor
    °¨°¢¼ö¿ëü
  • receptor site
    ¼ö¿ëüºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÚ¿Ã
  • labile methyl group
    ºÒ¾ÈÁ¤¸ÞÆ¿±â
  • methyl group
    ¸ÞÆ¿±â
  • adrenergic receptor
    ¾Æµå·¹³¯¸°¼ö¿ëü
  • androgen receptor
    ¾Èµå·Î°Õ¼ö¿ëü
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • antigen binding receptor
    Ç׿ø°áÇÕ¼ö¿ëü
  • receptor autoradiography
    ¼ö¿ëüÀÚ°¡¹æ»ç¼±¼ú
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • cholinergic receptor
    Äݸ°¼ö¿ëü
  • cold receptor
    ³Ã°¢¼ö¿ëü
  • complement receptor
    µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AST => aspartate aminotransferase
    ¾Æ½ºÆÄŽ¾Æ¹Ì³ëÆ®¶õ½ºÆä¶óÁ¦
  • aspartate
    ¾Æ½ºÆÄ¶óÁø»ê¿°
  • A1 receptor
    A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • A2 receptor
    A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • CR1 => complement receptor 1
    º¸Ã¼¼ö¿ëü 1
  • CR2 => complement receptor 2
    º¸Ã¼¼ö¿ëü 2
  • CR3 => complement receptor 3
    º¸Ã¼¼ö¿ëü 3
  • CR4 => complement receptor 4
    º¸Ã¼¼ö¿ëü 4
  • Gustatory receptor
    ¹Ì°¢¼ö¿ëü(Ú«ÊÆâ¥é»ô÷)
  • H2 receptor antagonist
    H2 ¼ö¿ëü ±æÇ×Á¦µé
  • Ig receptor
    ¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
  • Internalization, receptor
    ³»È­(Ò®ü§), ¼ö¿ëü(áôé»ô÷)
  • Kainate amino acid receptor
    Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
  • Kinesthetic receptor
    ¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
  • NMDA receptor
    ¿£¾Úµð¿¡ÀÌ ¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspartate
    ¾Æ½ºÆÄ¶óÁø»ê¿°
  • mitochondrial aspartate aminotransferase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
  • chloromethyl methyl ether
    Ŭ·Î·Î¸ÞÅÚ¿¡Å׸£
  • labile methyl group
    ºÒ¾ÈÁ¤¸ÞÆ¿±â.
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÝ.
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÚ¿Ã
  • methyl alcohol intoxication
    ¸ÞÆ¿¾ËÄÝÁßµ¶.
  • methyl dopa
    ¸ÞÆ¿µµÆÄ.
  • methyl dopa therapy
    ¸ÞÆ¿µµÆÄÄ¡·á(¡­ö½èþ).
  • methyl group
    ¸ÞÆ¿±â.
  • methyl nicotinamide
    ¸ÞÆ¿´ÏÄÚÆ¾¾Æ¹Ìµå.
  • methyl pentosan
    ¸ÞÆ¿ÆæÅä»ê.
  • methyl prednisolone
    ¸ÞÆ¿ÇÁ·¹µå´Ï¼Ö·Ð.
  • methyl red test
    ¸ÞÆ¿·¹µå°Ë»ç
  • methyl red test
    ¸ÞÆ¿·¹µå½ÃÇè.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Receptor
    ¼ö¿ë±â
    [¿¾ ¿ë¾î] ¼ö¿ë±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspartate trascarbamoylase
    ¾Æ½ºÆÄ¸£Æ®»ê(ß«)Æ®¶õ½ºÄ«¹Ù¸ðÀÏ·¹À̽º
  • malate-aspartate shuttle
    ¸»»ê(ß«).¾Æ½ºÆÄ¸£Æ®»ê(ß«) ¼ÅƲ
  • active methyl
    Ȱ¼º(üÀàõ)¸ÞÆ¿
  • angle methyl group
    ¾Þ±Û¸ÞÆ¿±â(Ðñ)
  • catechol-O-methyl transferase
    Ä«Å×ÄÝ-0-¸ÞÆ¿ Æ®¶õ½ºÆÛ·¹À̽º
  • labile methyl group
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ)¸ÞÆ¿±â(Ðñ)
  • O-methyl derivative
    O-¸ÞÆ¿À¯µµÃ¼(ë¯Óôô÷)
  • methyl green
    ¸ÞÆ¿±×¸°
  • methyl group
    ¸ÞÆ¿±â(Ðñ)
  • methyl-poor transfer RNA
    °ú(Íû)¸ÞÆ¿ Àü´Þ(îîÓ¹)RNA
  • N5-methyl tetrahydrofolic acid
    N5-¸ÞÆ¿»ç¼ö¼ÒÆú»ê(ß«)
  • methyl-trap hypothesis
    ¸ÞÆ¿Æ÷ȹ¼³(øÚüòàã)
  • adrenergic receptor
    ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) ¼ö¿ëü(áôé»ô÷)
  • alpha adrenergic receptor
    ¾ËÆÄ¾Æµå·¹³ª¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷)
  • alpha receptor
    ¾ËÆÄ¼ö¿ëü(áôé»ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â, ¼ö¿ëü, °¨¼öü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GRINA glutamate receptor, ionotropic, N-methyl-D-aspartate A
GRINB glutamate receptor, ionotropic, N-methyl-D-aspartate B
NMDAR N-methyl-D-aspartate receptor
NMDA N-methyl-D-aspartate
MPMP 10[(1-methyl-3-piperidinyl)-methyl]-1OH-phenothiazine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NMDAR N-Methyl-D-aspartate receptor
NMDAR1 N-methyl- D-aspartate receptor subunit 1
NMDAR1 N-methyl-D-aspartate receptor 1
NMDA N-methyl-D-aspartate receptor
NMDA N -methyl- D -aspartate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • methyl green-pyronin of nucleolus

    methyl group

    ¸ÞÄ¥±â
  • aspartate
    ¾Æ½ºÆÄ¶óÁø»ê¿°
  • aspartate aminotransferase
    ¾Æ½ºÆÄ¶óÁø»ê ¾Æ¹Ì³ëÆ®¶õ½ºÆÛ·¹À̽º
    ÀüÀÌ È¿¼Ò·Î¼­, L-as
  • AST : aspartate aminotransferaseÀÇ ¾àÀÚ.

    astasia abasia

    ±â¸³ º¸Çà ºÒ´ÉÁõ
    ´Ù¸®°¡ ´Ù¸¥ Á¡¿¡¼­´Â Á¶ÀýµÇ´Âµ¥µµ ºÒ±¸Çϰí, ±â¸³ ¶Ç ´Â º¸ÇàÀÌ ¾ÈµÇ´Â °Í.
  • catechol-o-methyl transferase
    catechol-o-methyl ÀüÀÌ È¿¼Ò
    ¿¡Çdz×ÇÁ¸°°ú ³ë¸£¿¡Çdz×ÇÁ¸°À» ºñȰ¼ºÈ­½ÃŰ´Â È¿¼Ò.
  • dihydroxy-propoxy-methyl guanine
    ´ÙÀÌÇÏÀ̵å·Ï½Ã-ÇÁ·ÎÆø½Ã-¸ÞÆ¿ ±¸¾Æ´Ñ
  • methyl
    ¸ÞÄ¥, ¸ÞÆ¿±â
    È­ÇÐ ¿øÀÚ´Ü ¶Ç´Â ±â.
  • methyl alcohol intoxication
    ¸ÞÆ¿ ¾ËÄÚ¿Ã Áßµ¶
    ¸ÞÆ¿ ¾ËÄÚ¿Ã
  • methyl dopa
    ¸ÞÆ¿ µµÆÄ
    3-hydroxy-al
  • methyl-methacrylate
    ¸ÞÆ¿ ¸ÞŸ¾ÆÅ©¸±·¹ÀÌÆ®
    C
  • 5-HT1 receptor antagonist
    5-HT1 ¼ö¿ë±â ±æÇ×Á¦
    ÀÏÂïÀÌ 5-hydroxytry
  • A1 receptor
    A1 ¼ö¿ëü, A1 ¼ö¿ë±â, A1 °¨¼ö±â
  • acetylcholine receptor
    ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü
  • alpha-adrenergic receptor
    ¾ËÆÄ-¾Æµå·¹³¯¸° ¼ö¿ëü
  • antigen receptor
    Ç׿ø ¼ö¿ëü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
N methyl D aspartate receptor <physiology> Glutamate receptor sub type (see excitatory amino acids). N methyl D aspartate receptor channels seem to be potentiated by intracellular arachidonic acid.
Acronym: NMDA
(26 Mar 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
receptors, n-methyl-d-aspartate A class of ionotropic glutamate receptors characterised by affinity for n-methyl-d-aspartate. Nmda receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
(12 Dec 1998)
aspartate <amino acid> A nonessential amino acid that plays a critical part of the enzyme in the liver that transfers nitrogen-containing amino groups, either in building new proteins and amino acids or in breaking down proteins and amino acids for energy and detoxifying the nitrogen in the form of urea.
Depleted levels of aspartic acid may occur temporarily within certain tissues under stress, but, because the body is able to make its own aspartic acid to replace any depletion, deficiency states do not occur.
Aspartic acid is abundant in plants, especially in sprouting seeds. In protein, it exists mainly in the form of its amide, asparagine.
The popular sweetener Aspartame is a combination of aspartic acid and phenylalanine. Aspartic acid is considered nontoxic.
(15 Nov 1997)
aspartate 1-decarboxylase <enzyme> A pyridoxal-phosphate protein that catalyses the alpha-decarboxylation of l-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining gaba levels in normal nervous tissues. The brain enzyme also acts on l-cysteate, l-cysteine sulfinate, and l-aspartate.
Chemical name: L-Glutamate-1-carboxy-lyase
Registry number: EC 4.1.1.15
(12 Dec 1998)
aspartate 4-decarboxylase Aspartate beta-decarboxylase;a carboxy-lyase converting l-aspartate to l-alanine (releasing CO2); it decarboxylates aminomalonate and (in bacteria) removes SO2 from cysteinesulfinate.
See: desulfinase.
(05 Mar 2000)
aspartate-alpha-decarboxylase <enzyme> Forms beta-alanine
Registry number: EC 4.1.1.11
Synonym: aspartate 1-decarboxylase
(26 Jun 1999)
aspartate aminotransferase <enzyme> An enzyme catalyzing the reversible transfer of an amine group from l-glutamic acid to oxaloacetic acid, forming alpha-ketoglutaric acid and l-aspartic acid; a diagnostic aid in viral hepatitis and in myocardial infarctions.
Synonym: aspartate transaminase, glutamic-aspartic transaminase, glutamic-oxaloacetic transaminase, serum glutamic-oxaloacetic transaminase.
(05 Mar 2000)
aspartate-ammonia ligase <enzyme> An enzyme that catalyses the formation of asparagine from ammonia and aspartic acid, in the presence of ATP.
Chemical name: L-Aspartate:ammonia ligase (AMP-forming)
Registry number: EC 6.3.1.1
(12 Dec 1998)
aspartate ammonia-lyase <enzyme> An enzyme that catalyses the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms.
Chemical name: L-Aspartate ammonia-lyase
Registry number: EC 4.3.1.1
(12 Dec 1998)
aspartate carbamoyltransferase <enzyme> An enzyme that catalyses the conversion of carbamoyl phosphate and l-aspartate to yield orthophosphate and n-carbamoyl-l-aspartate.
Chemical name: Carbamoyl-phosphate:L-aspartate carbamoyltransferase
Registry number: EC 2.1.3.2
(12 Dec 1998)
aspartate kinase <enzyme> An enzyme that catalyses the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine.
Chemical name: ATP:L-aspartate 4-phosphotransferase
Registry number: EC 2.7.2.4
(12 Dec 1998)
aspartate N-acetyltransferase <enzyme> Nervous system enzyme that mediates synthesis of n-acetylaspartic acid; utilises acetyl-CoA
Registry number: EC 2.3.1.17
(26 Jun 1999)
aspartate-saemialdehyde dehydrogenase <enzyme> An enzyme that catalyses the conversion of l-aspartate 4-saemialdehyde, orthophosphate, and NADP+ to yield l-4-aspartyl phosphate and NADPH.
Chemical name: L-Aspartate-4-saemialdehyde:NADP+ oxidoreductase (phosphorylating)
Registry number: EC 1.2.1.11
(12 Dec 1998)
aspartate transaminase <enzyme> An enzyme of the transferase class that catalyses the reaction of l-aspartate and 2-ketoglutarate to yield oxaloacetate and l-glutamate. The enzyme is a pyridoxal phosphate protein. In the liver the reaction transfers excess metabolic nitrogen into aspartate for disposal in the urea cycle.
Chemical name: L-Aspartate:2-oxoglutarate aminotransaminase
Registry number: EC 2.6.1.1
(12 Dec 1998)
aspartate-trna ligase <enzyme> An enzyme that activates aspartic acid with its specific transfer RNA.
Chemical name: L-Aspartate:tRNA-(Asp) ligase (AMP-forming)
Registry number: EC 6.1.1.12
(12 Dec 1998)
malate-aspartate shuttle A mechanism for the transfer of NADH reducing equivalents from the cytosol into the mitochondria using two isozymes of malate dehydrogenase and aspartate transaminase.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â;°¨°¢±â°ü;¼ö¿ëü
  • receptor site
    ¼¼Æ÷³» ¼ö¿ë ¿µ¿ª
  • methyl
    ¸ÞÆ¿
  • methyl alcohol
    ¸ÞÆ¿¾ËÄÚ¿Ã
  • methyl blue
    ¸Þƿû(û»öÀÇ À¯±â¿°·á,Çʱâ¿ë À×Å©³ª »ýü ¿°»ö¿¡ ¾¸)
  • methyl chloride
    ¿°È­ ¸ÞÆ¿
  • methyl chloridep
    ¿°È­ ¸ÞÆ¿
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á